Abzena will be attending the virtual Festival of Biologics event from 2nd – 6th November 2020.
There are two parts to the Festival of Biologics: three conferences covering Antibodies, Immunotherapy, Biosimilars and an exhibition featuring solutions for pharma and biotech.
We will be presenting at the event. Our Protein Engineering Group Leader, Arron Hearn will be speaking on Monday 2nd November 2020 at 3:00-3:20pm (GMT) on Applying Design and Developability for Optimal Candidate Selection
This presentation describes Abzena’s integrated approach to designing and selecting lead drug candidates for development and manufacture. This approach draws on developability concepts established from Abzena’s extensive experience in the field of biologics and bioconjugates.
Benefits of applying Developability concepts include:
· Allowing the early identification of risk factors and by doing so, providing scope to apply design alterations to fix/reduce liabilities.
· Reducing the likelihood of major issues arising at a later, more costly, stage of development.
· Selecting the best drug candidate(s) for development